List of investigational antipsychotics
This is a list of investigational antipsychotics, or antipsychotics that are currently under development for clinical use but are not yet approved. Chemical/generic names are listed first, with developmental code names, synonyms, and brand names in parentheses.
Receptor modulators
Monoamine receptor modulators
- Brilaroxazine (RP-5063, RP-5000; oxaripiprazole) – atypical antipsychotic (D2 receptor partial agonist, 5-HT2A receptor antagonist, other actions)[1]
- FKF-02SC (TGOF-02N) – atypical antipsychotic (D2 and 5-HT2A receptor antagonist, other actions)[2]
- Masupirdine (SUVN-502) – 5-HT6 receptor antagonist[3]
- N-methyl amisulpride (LB-102) – D2,3, 5-HT7, receptor antagonists (methylated version of amisulpride) [4]
- Ralmitaront (RG-7906, RO-6889450) – TAAR1 agonist[5]
- Ulotaront (SEP-856, SEP-363856) – 5-HT1A receptor and TAAR1 agonist[6]
- Usmarapride (SUVN-D4010) – 5-HT4 receptor partial agonist[7]
Glutamate receptor modulators
Acetylcholine receptor modulators
- Emraclidine (CVL-231) – M4 muscarinic acetylcholine receptor positive allosteric modulator.[9]
- KarXT (xanomeline/trospium) – combined M1 and M4 muscarinic acetylcholine receptor agonist and peripherally-selective muscarinic acetylcholine receptor antagonist.[10]
- ML-007 – M1 and M4 muscarinic acetylcholine receptor agonist.[11]
- NBI-1117568 (HTL 0016878) – M4 muscarinic acetylcholine receptor agonist.[12]
Cannabinoid receptor modulators
- Cannabidiol (CBD; GW-42003, GWP-42003, GWP-42003-P, ECP-012A; Arvisol, Epidiolex) – cannabinoid receptor modulator, antioxidant, other actions[13][14]
Other/mixed receptor modulators
- CVN766 – Orexin receptor type 1 antagonist[15]
- Deudextromethorphan (d-DM; AVP-786, CTP-786) – σ1 receptor agonist, serotonin–norepinephrine reuptake inhibitor, uncompetitive NMDA receptor antagonist, muscarinic acetylcholine receptor agonist, other actions[16][17]
- Roluperidone (CYR-101, MIN-101, MT-210) – 5-HT2A and σ2 receptor antagonist[18]
- TAK-041 (NBI 1065846) – GPR139 receptor agonist[19]
Enzyme inhibitors
- Luvadaxistat (NBI 1065844, TAK-831) – D-amino acid oxidase inhibitor.[20]
- MK-8189 – phosphodiesterase 10A inhibitor.[21]
- Osoresnontrine (BI-409306, SUB-166499) – phosphodiesterase 9A inhibitor[22]
- Sodium benzoate (SND-11, SND-12, SND-13, SND-14; Clozaben, NaBen) – D-amino acid oxidase inhibitor[23]
Ion channel modulators
Others
- TS-134 (TS-1341) – undefined mechanism of action[25]
See also
References
- "Brilaroxazine - Reviva Biopharmaceuticals - AdisInsight". adisinsight.springer.com. Springer. Retrieved 14 February 2020.
- "FKF 02SC - AdisInsight". adisinsight.springer.com. Springer. Retrieved 14 February 2020.
- "Masupirdine - Suven Life Sciences - AdisInsight". adisinsight.springer.com. Springer. Retrieved 14 February 2020.
- "N-methyl amisulpride - LB pharmaceuticals - AdisInsight". adisinsight.springer.com. Retrieved 2023-02-21.
- "Ralmitaront - AdisInsight". adisinsight.springer.com. Springer. Retrieved 10 July 2021.
- "SEP 363856 - AdisInsight". adisinsight.springer.com. Springer. Retrieved 14 February 2020.
- "SUVN D4010 - AdisInsight". adisinsight.springer.com. Springer. Retrieved 14 February 2020.
- "Pomaglumetad methionil - Denovo Biopharma/Eli Lilly and Company - AdisInsight". adisinsight.springer.com. Springer. Retrieved 14 February 2020.
- "Emraclidine - Cerevel Therapeutics - AdisInsight". adisinsight.springer.com. Retrieved 2023-02-15.
- "APN 1125 - AdisInsight". adisinsight.springer.com. Springer. Retrieved 14 February 2020.
- "ML 007 - AdisInsight". adisinsight.springer.com. Retrieved 2023-02-15.
- "HTL 0016878 - AdisInsight". adisinsight.springer.com. Retrieved 2023-02-21.
- "Cannabidiol - GW Pharmaceuticals - AdisInsight". adisinsight.springer.com. Springer. Retrieved 14 February 2020.
- "Cannabidiol - Echo Pharmaceuticals - AdisInsight". adisinsight.springer.com. Retrieved 14 February 2020.
- "CVN 766 - AdisInsight". adisinsight.springer.com. Retrieved 2023-02-19.
- "Deudextromethorphan - Avanir Pharmaceuticals - AdisInsight". adisinsight.springer.com. Springer. Retrieved 14 February 2020.
- Nguyen, Linda; Thomas, Kelan L.; Lucke-Wold, Brandon P.; Cavendish, John Z.; Crowe, Molly S.; Matsumoto, Rae R. (March 2016). "Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders". Pharmacology & Therapeutics. 159: 1–22. doi:10.1016/j.pharmthera.2016.01.016. ISSN 1879-016X. PMID 26826604.
- "Roluperidone - Minerva Neurosciences - AdisInsight". adisinsight.springer.com. Springer. Retrieved 14 February 2020.
- "TAK 041 - AdisInsight". adisinsight.springer.com. Retrieved 2023-02-21.
- "Luvadaxistat - Takeda - AdisInsight". adisinsight.springer.com. Retrieved 2023-02-21.
- "MK 8189 - AdisInsight". adisinsight.springer.com. Retrieved 2023-02-21.
- "BI 409306 - AdisInsight". adisinsight.springer.com. Springer. Retrieved 14 February 2020.
- "Sodium benzoate - SyneuRx - AdisInsight". adisinsight.springer.com. Springer. Retrieved 14 February 2020.
- "Evenamide - Newron Pharmaceuticals - AdisInsight". adisinsight.springer.com. Springer. Retrieved 14 February 2020.
- "TS 134 - AdisInsight". adisinsight.springer.com. Springer. Retrieved 14 February 2020.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.